Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine 0.05% for Post-refractive Surgery Dry Eye
NCT06043908Phase 4Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Aug 2022
- Primary completion
- Dec 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in dry eye syndrome (DED), sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06043908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06043908.